04:49 PM EDT, 07/01/2025 (MT Newswires) -- James E Flynn, 10% Owner, on June 27, 2025, sold 740,149 shares in ARS Pharmaceuticals ( SPRY ) for $13,663,151. Following the Form 4 filing with the SEC, Flynn has control over a total of 4,887,254 shares of the company, with 4,887,254 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1671858/000119380525000959/xslF345X05/e664668_4-arsp.xml